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Abstract
Bone development and length relies on the growth plate formation, which is dependent on
degradative enzymes such as MMPs. Indeed, deletion of specific members of this enzyme
family in mice results in important joint and bone abnormalities, suggesting a role in skeletal
development. As such, the control of MMP activity is vital in the complex process of bone
formation and growth. We generated a transgenic mouse line to overexpress TIMP3 in
mouse chondrocytes using the Col2a1-chondrocyte promoter. This overexpression in carti-
lage resulted in a transient shortening of growth plate in homozygote mice but bone length
was restored at eight weeks of age. However, tibial bone structure and mechanical proper-
ties remained compromised. Despite no transgene expression in adult osteoblasts from
transgenic mice in vitro, their differentiation capacity was decreased. Neonates, however,
did show transgene expression in a subset of bone cells. Our data demonstrate for the first
time that transgene function persists in the chondro-osseous lineage continuum and exert
influence upon bone quantity and quality.
Introduction
Bone formation is a complex three-dimensional process in which several signaling molecules
play a role in controlling skeletal development. Crucially, components of the extracellular
matrix (ECM) and their remodelling by matrix metalloproteinases (MMP) play critical roles in
cartilage and bone structure and function. The process of endochondral ossification, which is
essential for bone formation and growth, involves a cartilage intermediate. During this pro-
cess, mesenchymal condensation differentiates into a cartilage template, rich in collagen type
II. Chondrocytes become hypertrophic and produce a calcified cartilage matrix, which is
finally replaced by bone matrix, rich in collagen type I, produced by invading osteoblasts.
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This remodelling of cartilage is dependent on degradative enzymes such as MMP. Deletion of
these enzymes in mice result in important joint and bone abnormalities, suggesting a role in skel-
etal development [1–3]. As such, the control of their activity is vital in the complex process of
bone formation and growth. Although deletion of some regulators of matrix remodeling do not
seem to affect bone development severely, they nonetheless result in pathologies that remain
undisclosed. One such example is the deletion of Tissue inhibitor of metalloproteinases (TIMP),
which are the major natural inhibitors of MMPs. In particular TIMP3 has been shown to be able
to inhibit the activity of MMPs and A Disintegrin and Metalloproteinase (ADAMs) [4, 5]. In
addition, TIMP3 was shown to be expressed in embryonic and early postnatal stages in tissues
undergoing extensive remodelling and in adult tissues with rapid turnover [6–12]. This therefore
suggests a role of TIMP3 in controlling matrix turnover in various tissues. Although TIMP3
deletion did not appear to induce any overt skeletal pathology [13], no in depth analysis of the
early bone development and adult bone phenotype have yet been described.
The mechanical properties of bones are essential to maintain their function to withstand
loads and changes in the bone’s structure and mass can alter these properties. Thus bone devel-
opment and growth, which involves a cartilage intermediary through endochondral ossifica-
tion or growth plate, has a direct impact on the strength of bones in later life. Our aim is
therefore to use murine transgenic approaches to define the importance of TIMP3 expressed
by chondrocytes on bone development and function in adults. Mice that overexpress TIMP3
specifically in chondrocytes under the control of the promoter/enhancer collagen type II
(Col2a1) gene were used and we find major defects in bone formation and in bone structure
and mechanical properties in adult mice, which suggests a control of bone by chondrocytes,
possibly via the transdifferentiation of growth plate hypertrophic chondrocytes into bone cells.
Results
High levels of TIMP3 overexpression are lethal postnatally.
Transgenic mice exploiting a 3kb promoter and 3kb first intron of the Col2a1 gene to drive
overexpression of human TIMP3 (TIMP3 (Tg/Tg)), followed by an IRES and ß-galactosidase
gene (Fig 1A) showed chondrocyte-specific expression during development (Fig 1B–1D) con-
firming restriction of the transgene to cartilage. Several murine lines expressing different levels
of human TIMP3 were produced (Fig 1E). Those possessing highest TIMP3 overexpression
levels (line 1) died within 2 weeks of birth and exhibited marked stunting of growth. Skeletal
comparison of Tg/Tg mice to WT littermates revealed that most ribs and knee joints showed
accumulation of matrix, which stained positively with Alcian blue for proteoglycans, as well as
deficient ossification levels consistent with the failure to remodel the matrix in order to facili-
tate bone formation (Fig 1G). High expression of the transgene in P14 mice (14 days old post-
natal) also showed restricted endochondral ossification, disorganised cartilage with excessive
matrix and fewer chondrocytes in epiphyseal locations where secondary ossification centres
had otherwise formed in WT mice (Fig 1I and 1H); Tg/Tg mice also showed disorganised and
deficient metaphyseal trabecular bone compared with WT littermates.
Ectopic TIMP3 transgenic expression is seen in proliferating
chondrocytes of altered growth plates of TIMP3 transgenic mice
Amongst the different TIMP3 transgenic mouse, another line (line 19), expressed an intermedi-
ate level of the transgene and survived into adulthood. It was found that breeding of this line to
homozygosity disclosed early defects in bone length and growth plate organisation. Indeed,
TIMP3 Tg/Tg mice (line 19) were identifiable by virtue of being born smaller up to P7 (Fig 2A),
Col2a1-Driven TIMP3 Controls Bone Structure
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with shorter limbs compared to WT controls (Fig 2B and 2C). This difference in size, however,
was no longer visible at P14 and 8 weeks of age.
Histological analysis of their growth plates (Line 19) revealed a ~40% reduction in the
width of the growth plate (Fig 3A) with marked decreases in the proliferating and hypertrophic
zones (Fig 3B). In contrast, heterozygous TIMP3 transgenic mice were not affected (data not
shown). In situ hybridisation (Fig 3C) for collagen type II and X mRNA in P14 mouse tibiae
showed a deficit in the width of both proliferative and hypertrophic growth plate zones in
Timp3 Tg/Tg mice, respectively. Indian hedgehog and parathyroid related protein mRNA
(not shown) were distributed similarly with likewise intensity in both Timp3 Tg/Tg and WT
mice, albeit in a reduced area of the hypertophic zone. TIMP-3 mRNA was restricted to the
pre-hypertrophic zone in WT mice but was additionally expressed in the proliferative zone in
the Tg/Tg mice (Fig 3C). Ectopic expression of neither collagen type II nor TIMP-3 transgene
was seen in the subchondral bone or along the cortical bone length (data not shown). Line 19
mice were used for the rest of this study.
Col2a1-driven TIMP3 overexpression decreases adult murine bone
mass.
Tibiae from 8 week-old mice were micro-CT scanned and analysed. This showed that bone
in the trabecular compartment of TIMP3 Tg/Tg mice exhibited significantly lower mass,
Fig 1. High TIMP3 overexpression in mice from line 1 induced defective skeletal development and
growth. A, Diagram depicting the transgene utilized for overexpression of TIMP3 restricted to chondrocytes
using the Col2a1 promoter and enhancer, followed by LacZ. B-D, LacZ staining showing expression of the
transgene in TIMP3 Tg/+ in the cartilaginous skeletal elements in whole-mount embryos (B) and histological
sections across the whole embryo (C; magnification x4) and in the developing forelimb (D; magnification x10); E,
TIMP3 protein amount (relative light unit (RLU) per ng of total protein) in each transgenic line created. F-I, severe
skeletal phenotype in TIMP3 Tg/Tg line 1 with high expression of the transgene, with significant differences in
overall pup size at P14 (F), in whole mount pups stained with Alizarin red and Alcian blue and magnified view of
the knee (G) with delayed ossification of the epiphysis with increased amount of cartilage tissue (blue).
Histological sections of knee joint epiphysis stained with Alizarin red and Alcian blue in WT (H) and TIMP3 Tg/Tg
(I) showed lack of secondary ossification centre in the transgenic mouse (Magnification x10).
doi:10.1371/journal.pone.0167971.g001
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with decreased BV/TV and trabecular thickness, and modification in bone structure with
elevated trabecular pattern factor and decreased trabecular number (Table 1). Von Kossa
staining confirmed decreased trabecular bone mass in TIMP3 Tg/Tg mice (Fig 4A). Simi-
larly, analysis of cortical bone by microCT showed decreased total bone area, bone perime-
ter, MMI (Mean polar moment of inertia) and medullary area (Table 1). These data indicate
that TIMP3 overexpression driven via Col2a1 modifies trabecular and cortical bone mass
and architecture.
Fig 2. Bone and growth plate lengths are reduced with TIMP3 overexpression in young growing mice.
TIMP3 Transgenic line 19 with lower transgene expression levels were used for bone analysis. A. Body
weight of WT and TIMP3 Tg/Tg mice at 7 and 14 days, and at 8wks. B. Tibia and Humerus length of the
marrow cavity relative to the total length at E16.5 and bone length at 8 weeks of age (n = 5). C. Histological
pictures of the tibia of WT and TIMP3 Tg/Tg at E16.5, stained with Collagen type 10 to show the edges of the
marrow cavity. Dashed lines show the edges of the whole bone (outer lines) and edges of the marrow cavity
(middle lines). Student’s t-test was used for statistical analysis (* for p<0.05, **** for p<0.0001).
doi:10.1371/journal.pone.0167971.g002
Fig 3. Thinner growth plates support bone length shortening in growing TIMP3 Tg/Tg mice (Line 19). A,
histological representation stained with H&E of the growth plate from WT and TIMP3 Tg/Tg mice at P14 (Magnification
x10). B, quantification of the width of the growth plate (GP), the proliferating zone (PZ) and hypertrophic zone (HZ) at
P7 and P14. (n = 5; Student’s t-test; * for p<0.05). C, In situ hybrization for Collagen type II (Col II, in all chondrocytes),
Collagen type X (Col X; marker of hypertrophic chondrocytes), Indian Hedghog (Ihh, found in the hypertrophic zone
cells) and TIMP3 mRNA in the tibia of P14 WT (top panels) and TIMP3 Tg/Tg (bottom panels). Of importance, TIMP3
mRNA was found mainly in the prehypertophic zone cells in the WT, but we additionally found in all other chondrocytes
including in the proliferating and hypertrophic zones (Magnification x4).
doi:10.1371/journal.pone.0167971.g003
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Bone mechanical properties are compromised in Col2a1-driven TIMP3
Tg/Tg mice.
To examine whether this diminution of mass and compromised bone structure in Col2a1-dri-
ven TIMP3 Tg/Tg mice also influenced bone’s functional load-bearing qualities, 3-point bend-
ing tests were performed on femurs of 8wk-old mice and showed that stiffness, yield load and
ultimate load were all significantly lower in TIMP3 Tg/Tg compared to WT control mice (Fig
4B–4D).
In addition, the spatial strain distribution over the medial side of the tibia was calculated,
based on the three components of displacement measured using a digital image correlation
system. Fig 4E shows only the strain in the axial (loading) direction, as transverse strain and
shear strain both had relatively low magnitude in comparison. Strain maps indicate a non-uni-
form strain field across the surface of the tibia, with the axial compression resulting in tension
on the medial tibia because of its curved shape, in agreement with previous studies [14]. Con-
sistent with compromised load-bearing strength in bones of these TIMP3 Tg/Tg mice, load-
engendered tissue strains were increased in magnitude and showed modification in their pat-
tern compared with WT mice. Specifically, the medial surface of the tibia of TIMP3 Tg/Tg
mice had a maximum strain of 0.57 ± 0.02% vs. 0.41 ± 0.01% in WT, with an average strain of
0.35 ± 0.02% vs 0.026 ± 0.006%, respectively. Load-deformation curves were similar both dur-
ing each repeated loading episode and for all mice within each genotype, indicating there was
no load-related failure. However, TIMP3 Tg/Tg had a 20% greater compressive extension than
WT.
In order to resolve the contribution of mineralized collagen fibrils and mineral crystals to
overall tissue strain in bone of TIMP3 Tg/Tg mice, we coupled in situ tensile testing of bone
with simultaneous small angle X-ray scattering (SAXS) and wide angle X-ray diffraction
(WAXD). These data showed that at small tissue strains, bone from TIMP3 Tg/Tg mice has
Table 1. Trabecular and cortical structure is modified in TIMP3 Tg/Tg and WT mice at 8wks of age.
Trabecular WT TIMP3 Tg/Tg p-value
BV/TV 12.12 (±0.66) 8.49 (±0.57) 0.0014
Tb.Th 0.052 (±0.001) 0.046 (±0.001) 0.0036
Tb.Sp 0.24 (±0.015) 0.26 (±0.018) 0.3801
Tb.N 2.32 (±0.12) 1.81 (±0.09) 0.0106
Tb.Pf 27.66 (±0.69) 33.69 (±1.14) 0.0009
SMI 2.20 (±0.06) 2.38 (±0.02) 0.0685
Cortical WT TIMP3 Tg/Tg p-value
T.Ar 1.11 (±0.02) 0.90 (±0.03) <0.0001
T.Pm 4.11 (±0.04) 3.69 (±0.06) <0.0001
B.Ar 0.73 (±0.01) 0.61 (±0.02) <0.0001
MMI(polar) 0.18 (±0.007) 0.12 (±0.007) <0.0001
Ecc 0.55 (±0.01) 0.56 (±0.01) 0.6326
Cs.Th 0.22 (±0.003) 0.21 (±0.007) 0.0716
M.Ar 0.37 (±0.01) 0.29 (±0.02) 0.0023
BV/TV: Bone Volume/Total Volume (%); Tb.: Trabecular; Th.: Thickness (mm); Sp.: Separation(mm); N.:
Number (1/mm); Pf.: Pattern Factor (1/mm); SMI: Structure Model Index; TA: Total Area (mm2); T.Pm: Total
Perimeter (mm); BA: Bone area (mm2); MMI(polar): Mean polar moment of inertia (mm4); Ecc: Mean
eccentricity; Cs.Th: Cross-sectional thickness (mm); MA: Medullary Area (mm2). Statistical significance
measured by Student’s t-test. N = 9 TIMP3 Tg/Tg, n = 17 WT.
doi:10.1371/journal.pone.0167971.t001
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increased fibril strain, implying that the fibrils are less stiff compared with WT (Fig 4E). Differ-
ences in fibril nanomechanics are possibly caused by lower levels of inter-fibrillar shear trans-
fer due to reduced mineralization.
As these bone qualities are likely a functional property of osteoblasts or osteocytes, not
chondrocytes, these data together provide strong indication that the TIMP3 transgene driven
by chondrocyte-selective Col2a1 exerts either direct or indirect effects on bone mass and qual-
ity. Alternatively, these data may indicate that the influence of a Col2a1-driven transgene per-
sists across the newly appreciated chondro-osseous lineage continuum to functional impact
osteoblast behavior.
Fig 4. TIMP3 overexpression decreases tibial bone mechanical properties from macroscale to
nanoscale mechanics. A, Von Kossa staining of tibia epiphysis and metaphysis of WT and TIMP3 Tg/Tg
mice showed decreased trabecular bone in TIMP3 Tg/Tg mice (Magnification x2). B-D Mechanical properties
of the femur showing decreased Stiffness, yield force and ultimate force in TIMP3 Tg/Tg mice (Student’s t-
test; *** for p<0.001, **** for p<0.0001; n = 8 WT, n = 12 Tg/Tg). E, Axial strain heat map under
compression along the tibial shaft (n = 4). F, Strain curves against tissue stress, mineral fibril strain and
mineral strain in WT (blue) and TIMP3 Tg/Tg (red; n = 5).
doi:10.1371/journal.pone.0167971.g004
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Osteoblasts from Col2a1-driven TIMP3 Tg/Tg mice exhibit modified
behaviour in vitro.
To define whether Col2a1-driven TIMP3 overexpression modified osteoblast function, behav-
iour of primary osteoblasts extracted from tibiae of 8wk-old WT and TIMP3 Tg/Tg mice were
compared. Consistent with lower rates of growth, osteoblasts from TIMP-3 Tg/Tg mice were
found in significantly lower numbers than cells from WT mice after an extended culture in
vitro. (Fig 5). Furthermore, alkaline phosphatase activity and mineralisation were also both
significantly lower in osteoblasts from TIMP3 Tg/Tg bone. Under osteogenic conditions,
markers of osteoblastic differentiation, including Runx-2, alkaline phosphatase, osteocalcin
and collagen type I mRNA expression levels were all significantly lower (Fig 5) in osteoblasts
from TIMP3 Tg/Tg compared with WT osteoblasts; levels of none of these mRNA transcripts
differed in WT and TIMP3 Tg/Tg osteoblasts in non-osteogenic control conditions. These
data suggest that osteoblasts isolated from TIMP3 Tg/Tg mice, maintained in isolation of
Col2a1-driven transgene expressing chondrocytes, have perturbed osteogenic potential. Carti-
lage markers, Sox9 and aggrecan, as well as expression of the transgene detected by LacZ
reporter were not detectable in any of these osteoblast cultures.
Finally, we interrogated the origin of this impairment in osteoblast function by exploring
the distribution of the ß-galactosidase gene (LacZ) reporter in transgenic mice in vivo. Despite
transgene overexpression via a Col2a1 promoter, cells expressing ß-galactosidase were found
not only throughout cartilage, but also in some osteoblasts in both the trabecular and cortical
bone compartments, and some osteocytes at P11 (Fig 6).
Discussion
In this study we overexpressed TIMP3 using a Col2a1 promoter to achieve specificity to chon-
drocytes, and obtained a set of transient defects in growth plate and permanent defects in
bone. Specifically, Line 19 is a mouse line that overexpressed TIMP3 transgene at low level to
allow the mouse to survive during development, yet high enough to produce a transient carti-
lage phenotype only in homozygote mice. We found that the transgene-induced transient phe-
notype in the growth plate in this line 19, with shortening of the proliferating zone and overall
bone length in development and early life, was followed by an effective ‘catch-up’ by eight
weeks of age. In contrast, early deficiencies in structure and mechanical bone properties in the
skeleton of Col2a1-driven TIMP3 transgenic mice persisted into adulthood. Although we have
not defined a mechanism in this study, there are many possibilities explaining how the matrix
protein TIMP3 overexpressed by chondrocytes affects osteoblast function, which are discussed
below.
In agreement with previous work [6], TIMP3 mRNA levels detectable by in situ hybridiza-
tion in WT mice were relatively low and restricted to chondrocytes in the pre-hypertrophic
growth plate zone. However, TIMP3 mRNA expression was more widespread in the Col2a1--
driven TIMP3 Tg/Tg, extending additionally into the proliferating growth plate zone. These
changes were not linked with modified expression of the essential cartilage signaling mole-
cules, Indian hedgehog (Ihh) or parathyroid hormone/ parathyroid hormone-related peptide
(PTH/PTHrP). These data are in accord with similar findings in MMP-14 null mice [1]. In
addition, we found that like MMP-14 and MMP-16 null mice, proliferating zone shortening
and decreased chondrocyte proliferation likely explain the diminution in bone length [1, 2].
This contrasts, however, with the phenotype of both MMP-13 and MMP-9 null mice, in which
such severe impairment in endochondral bone growth was instead characterized by marked
elongation of the hypertrophic zone, along with diminished ECM remodeling, prolonged
chondrocyte survival, delayed vascular recruitment and similarly defective trabecular bone
Col2a1-Driven TIMP3 Controls Bone Structure
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Fig 5. Primary osteoblasts culture from WT and TIMP3 Tg/Tg mouse tibiae at 8wks of age showed
decreased cell number and differentiation capacity. A. Cell number was decreased in TIMP3 Tg/Tg mice. B-F,
alkaline phosphatase activity (B) and mRNA expression of RUNX-2 (C), Osteocalcin (OCN, D), Alkaline
phosphatase (ALP, E) and Collagen type I (COL1A1, F) in WT (white bars) and TIMP3 Tg/Tg (grey bars) mouse
osteoblasts with and without osteogenic medium treatment (OM, to induce osteogenic differentiation, hashed bars),
showing an increase in expression in all genes with osteogenic differentiation in WT cell, compared to a significant
Col2a1-Driven TIMP3 Controls Bone Structure
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formation [3]. It is therefore possible that the skeletal development phenotype we observed in
TIMP3 transgenic pups was the product of relatively elevated levels of local inhibition of MMP
activity. This would be consistent with proposed roles for MMPs and TIMPs in skeletal devel-
opment with both the function of TIMP3 as a matrix-bound inhibitor of both aggrecanases
such as ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) and
MMP molecules [5] and as a pivotal controller of normal cartilage matrix turnover [4, 15].
As well as playing an important role in skeletal development, MMP and TIMPs affect bone
growth and remodeling, contribute to modulation of bone mass in response to mechanical
loading and are involved in fracture healing and in osteoblast-to-osteocyte transition [16–22].
TIMP3 overexpression in chondrocytes and its matrix-enrichment may therefore exert para-
crine actions on MMP activity in bone that could explain the decreased bone mass and thinner
cortices found in this Col2a1-driven TIMP3 Tg/Tg. Indeed, decreased bone mass has also
stunted promotion of these genes during differentiation in TIMP3 Tg/Tg cells. G, representative images of Alkaline
phosphatase activity visualised using Fast Blue dye. (3 replicate wells from 3 plates per treatment and per genotype
taken from a total of n = 4 WT and n = 6 Tg/Tg mice; One Way ANOVA test; * for p<0.05; ** for p<0.01; *** for
p<0.001).
doi:10.1371/journal.pone.0167971.g005
Fig 6. Beta-galactosidase staining from the TIMP3-LacZ transgene expression on the Col2a1 promoter/
enhancer was found in bone cells at P11. Cells expressing the trangene-LacZ stained blue (beta-galactosidase)
and were found in the epiphyseal cartilage (A) and in the trabecular (B) and cortical (C) bone cells (arrows). D-F show
non-transgenic controls, with positive blue staining showing osteoclasts, and therefore not linked to the transgene,
but no osteocytes embedded in the bone matrix were beta-galactosidase-positive. (A and D Magnification x2; B-C,
E-F Magnification x20)
doi:10.1371/journal.pone.0167971.g006
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been observed in mice deficient in certain MMPs, including MMP-9 and MMP-14 as well as
in MMP-9/-13 double knock out mice [1, 23]. In addition, MMP-13 null mice also exhibit
decreased bone quality and increased fracture risk [3, 18]. Our data suggest that the bone phe-
notype seen in Col2a1-driven TIMP3 Tg/Tg mice is a product of increased paracrine MMP
inhibition in bone by TIMP3 and that ECM TIMP3 is an important regulator of bone
remodeling.
Only few studies have reported an adult bone phenotype in chondrocyte-specific murine
mutants. Conditional deletion of MMP-13 in chondrocytes failed to reproduce the shorter
bone and increased bone volume observed in global MMP-13 null mice, suggesting that chon-
drocyte-specific loss of MMP-13 is not sufficient to explain this modification in bone architec-
ture [3, 24]. Unsurprisingly, chondrocyte-selective deletion of collagen type II resulted in
smaller mice with shorter bones and thinner trabeculae [25]. Interestingly, a recent paper
describes the role of chondrocyte-specific ATF4 (Activating Transcription Factor 4) in bone
development and architecture [26]. Akin to our findings, the authors showed that chondro-
cyte-selective ATF4 deficiency (as opposed to TIMP3 overexpression) also delayed formation
of ossification centers, resulted in short bones and also decreased bone mass and osteoblast dif-
ferentiation; which were all rescued by cartilage-selective ATF4 overexpression. Although the
mechanisms of action were found to involve Ihh in these chondrocyte-selective ATF4 gain-of/
loss-of-function mice and, therefore, likely differ from those in our TIMP3 Tg/Tg mice, these
data suggest that transgene overexpression using a cartilage-targeted promoter can indeed
affect bone structure and function. Our study extends these observations suggesting that these
hitherto ‘off-target’ effects impact bone structure and function in adults.
Crosstalk between cartilage and bone has been described previously. Indeed, co-culture of
chondrocytes with osteoblasts has been found to restrict mineralization [27]. In addition, it
has been suggested that such crosstalk via the transfer of proteins can also occur between artic-
ular cartilage and subchondral bone in osteoarthritic joints in vivo [28]. It has also been shown
that Ihh and other factors secreted by cartilage can affect osteoblast differentiation and that
fibroblast growth factors, BMPs and Wnts might also contribute similarly to this crosstalk [26,
29]. This supports the possibility that TIMP3 expressed by chondrocytes may act on osteo-
blasts and bone via a paracrine route. Insulin growth factor-1 (IGF-1) is one such signaling
molecule that is expressed by chondrocytes that may affect bone cells. Indeed, chondrocyte-
targeted deletion of IGF-1 (using the identical Col2a1 promoter used herein) produced a bone
phenotype resembling that which we observed in TIMP3-Tg/Tg mice, with reduced bone
length, periosteal and endosteal perimeters [30]. However, further studies are needed to deter-
mine whether the bone phenotype described herein is a result of the embryonic defects due to
TIMP-3 overexpression or a direct effect of chondrocytes on bone cells and tissue.
Finally and most intriguingly, our studies unveil an impaired osteogenic potential in osteo-
blasts isolated from Col2a1-driven TIMP3 Tg/Tg mouse bone, maintained in vitro. Isolation
from both the matrix and any paracrine control from the Col2a1-targeted chondrocytes
points, however, to an alternative explanation for the adult bone phenotype in the Tg/Tg mice.
Any alternative explanation would need also to accommodate the lack of any detectible colla-
gen type II mRNA or TIMP3 transgene expression in these isolated osteoblasts in vitro. In
addition, TIMP3 overexpression in bone marrow cells lead to increased bone formation, sug-
gesting the bone phenotype described in our manuscript is not due to ectopic TIMP3 expres-
sion from hematopoietic stem cells in our system [31].
An exciting explanation appears to have been recently afforded by exciting lineage tracing
experiments which have demonstrated that Col2-cre-targeted cells contributed not only to the
chondrocyte population of skeletal cells but also perichondrial cells and, indeed, Col1-GFP
positive osteoblasts, osteocytes and Cxcl12 high stromal cells in marrow in mice at postnatal
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day 3 [32]. Pulse chase studies also showed that histologically-tracked Col2-cre-ER, as well as
Aggrecan-cre-ER (system including tamoxifen-dependent Cre recombinases) labelled cells
contribute to osteoblast and stromal cell populations. In our study, staining in Col2a1-driven
TIMP3 Tg/Tg mouse bones for ß-galactosidase, an integral component of the TIMP3 trans-
gene ‘cassette’ expressed only whilst Col2a1 is actively transcribed, did not disclose any positive
labelling of osteoblasts in 8 week-old mice. In contrast, many bone cells in both trabecular and
cortical bone compartments were indeed ß-galactosidase positive in P11 newly born Col2a1--
driven TIMP3 Tg/Tg mice and this was never associated with detectible TIMP3 or Col2
mRNA. Together with recent tracking studies, our data suggest that transient TIMP3 overex-
pression, at the early Col2a1-expressing phase in this chondrocyte-to-osteoblast lineage con-
tinuum, engenders modification of cell behavior that persists into late osteoblast phases when
neither Col2a1 nor the TIMP3 transgene is actively transcribed. Similar persistence could be
reflected in the contribution of bone marrow cells, which transiently express Col2a1, to the
osteoblast lineage [33] or in the chondrocyte-to-osteoblast transdifferentiation observed dur-
ing bone fracture healing in adult mice [34]. Although prior studies showing modified in vitro
osteoblast differentiation also in chondrocyte-selective ATF4-deficient mice [26], the cellular
mechanism by which TIMP3 exerts its persistent impact in osteoblasts remains to be defined.
In conclusion, our data have established modification in skeletal development and mainte-
nance in mice harbouring a Col2a1-driven TIMP3 transgene. Our observations indicate that
chondrocyte-selective overexpression of TIMP3 disrupts endochondral growth, particularly
during early development, and produces more persistent changes in skeletal structure which
compromise the functional integrity of bone in post-natal and adult life. Our data also point to
a persistence downstream impact of transient TIMP3 transgene expression which extends to
influence osteoblast function within the chondrocyte-to-osteoblast lineage continuum to
achieve these long-term changes in bone quantity and quality.
Materials and Methods
Generation of TIMP3 transgenic mice
Creation of the transgenic mice and all studies were conducted under with U.K. Home Office
project licenses. A transgenic construct containing collagen IIα1 chain (Col-2a1) proximal
promoter region (3000 bp), the first exon (237 bp), the first intron (3020 bp) [35], was used to
drive expression of human TIMP-3, an IRES (internal ribosomal entry site) sequence and LacZ
with nuclear localizing signal. Not I was used to remove back-bone vector (pBluescript) and to
produce 11.3-kb fragment that was microinjected into fertilized -C57BL/10 × CBA F1 eggs.
Founder mice were identified by analysis of genomic DNA with Southern blot. TIMP-3
mRNA expression in E15.5 embryo were confirmed by qRT-PCR with human TIMP-3 specific
primer and probe (QuantiProbe1 kit, Qiagen). Homozygous and heterozygous transgenic
animals were identified with TaqMan probe for β-galactosidase (sence: 5’- GTG CAC GGC
AGA TAC ACT TG-3’, antisence: 5’- AAC GGT AAT CGC CAT TTG ACC AC-3’, TaqMan
probe; 5’ FAM-TCA GCC GGA AAA CCT ACC GGA TTG A–BHQ 3’) and mouse 18S
(sence: 5’- GAC CAT AAA CGA TGC CGA CTG -3’, antisence: 5’- CCC TTC CGT CAA TTC
CTT TAA G -3’, TaqMan probe; 5’ HEX- CTT CCG GGA AAC CAA AGT CT–BHQ 3’) as
described previously [36].
Mice were housed in groups of up to 6 in individually vented cages maintained at 21 ± 2˚C
on a 12-hour light/dark cycle with ad libitum food (RM3; Special Dietary Systems) and water.
All experimental protocols were performed in compliance with the UK Animals (Scientific
Procedures) Act 1986 regulations for the handling and use of laboratory animals. Mice were
monitored daily for any health and welfare issues from birth, including any possible defects or
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significant change in size during the first two weeks. Mice were euthanised by an approved
Schedule 1 method (by rising concentration of CO2 or by cervical dislocation for adult mice).
Micro-computed tomography (microCT) analysis
Tibiae from 8week-old male WT (n = 17) and TIMP3-Tg/Tg (n = 9) mice were fixed, stored in
70% ethanol and scanned using a microCT system (Skyscan 1176, Belgium). High resolution
scans with an isotropic 5μm voxel size were attained, reconstructed using NRecon v1.6.4.0 and
analysed using Dataviewer v1.4.4 and CTAn v1.11.6.0+ (Skyscan, Belgium). Cortical analysis
was performed on a 0.5mm segment starting at 37% of the tibial length, and the trabecular
region included 200 slices (1mm) immediately distal to the growth plate. Histomorphometric
analysis was performed by Skyscan software (CT-Analyzer version 1.5.1.3; [37]). For trabecular
bone analysis, regions of interest were drawn to exclude the cortical shell, and three-dimen-
sional algorithms were used to determine relevant parameters, including: bone volume (BV)
percentage, BV/total volume (BV/TV), trabecular thickness (Tb.Th), number (Tb.N) and sepa-
ration (Tb.Sp), Trabecular pattern factor (Tb.Pf) and Structure Module Index (SMI). For corti-
cal bone analysis, two-dimensional computation was used, and parameters included total area
(TA), cortical area (CA), medullary area (MA), Total Perimeter (T.Pm), Cross-sectional thick-
ness (Cs.Th), Mean polar moment of inertia (MMI), Mean eccentricity (Ecc).
Femur three-point bending
After microCT scanning, right femurs of n = 8 WT and n = 12 TIMP3Tg/Tg mice were tested
until fracture by three-point bending using a standard materials testing machine (5866 Instron,
Instron, Norwood, MA, USA). Femurs were loaded at the mid-diaphysis in the anterior-poste-
rior direction with a deflection rate of 50μm/s. Force-deflection curves were analysed with a cus-
tom program (Matlab, MathWorks Inc, MA, USA) to measure the bending stiffness (S: slope of
the linear elastic deformation), the yield force (Fyield, limit between the elastic and plastic defor-
mation) and ultimate force (Fult, maximum force sustained). The plastic (post-yield) behaviour
was assessed by the ratio of plastic/total work to fracture (Rp/tW, i.e. ratio of the area under the
curve from the yield point to the fracture point over the total area under the curve).
Bone surface strains using digital image correlation (DIC)
Left and right tibiae, n = 4 mice each group, were exposed. Bones were subsequently covered
with a thin layer of matt, water-based, white paint, and speckled with matt, acrylic, black ink
using a high precision air brush. Legs were loaded at a rate of 8 N/min up to 12 N using custom
built loading cups attached to a material testing machine (Instron 5800, High Wycombe, UK),
which applied an axial load across the knee and ankle joints [14]. Two CCD cameras (100 mm
lenses, GOM GmbH, Germany) mounted on a tripod were positioned horizontally in front of
the loading fixture, at a distance of 42 cm, to provide a 15 x 12 mm field of view (7.5 x 10.9 μm
resolution) with the depth of focus field of 1.2 mm. Along their axis, the two cameras were sep-
arated by 148 mm and they were rotated towards each other meeting at 25˚ angle on the bone
surface of interest. Calibration was conducted by using a high-precision 15 mm x 12 mm panel
(GOM GmbH, Germany). The sample was enlightened by two light-emitting diode lamps
with polarised filters. During the loading, images of the medial side of the speckled tibiae sur-
face were recorded at 1 N interval using the ARAMIS 5M System (GOM GmbH, Germany),
with a resolution of 7.5x10.9 μm. Post processing of the images was done using 19x19 pixel
square facets, with 15 pixels step facet. All the strains were computed with a computation size
of 5 and a validity quote of 65%. Three images were taken in the un-deformed state in order to
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allow for the determination of the noise (inverse of accuracy) during the experiments. Max
and mean strain on the medial surface were calculated.
In situ Small Angle X-ray Scattering (SAXS) and Wide Angle X-ray
Diffraction (WAXD) tensile tests
The ulnae of n = 5 TIMP3 Tg/Tg and n = 5 WT mice were dissected and soft tissue removed.
All bones were maintained hydrated at 25˚C with phosphate-buffered saline (PBS) after dissec-
tion and for the entire duration of the testing. A similar set-up that was previously used was
applied for this test [38]. Bones were then inserted into a microtensile tester (Diamond Light
Source (DLS)) that pulls the bones apart at both ends ensuring the sample remains at the same
position with sub-micron precision. The bones were loaded in tension at a displacement rate
of 2 μm∕s with a 110 N load cell (model 31- RDP Electronics, UK). The microtensile tester rig
was positioned in beamline I22 at the DLS synchrotron radiation, such that SAXS/WAXD
data were collected simultaneously with mechanical loading. During mechanical testing, sam-
ples were exposed to a microfocus X-ray (wavelength λ = 0.8857 Å, energy 14 KeV, size beam
~10μm2) for 0.2 s every 1% motor strain only during the elastic region of the load-displace-
ment curve, limiting the total X-ray exposure of the bone. A high-speed Pilatus detector (Area
Detector Systems Corporation) was positioned at approximately 1,000 and 250 mm from the
sample, respectively, to collect SAXS and WAXD data.
The tissue strain was considered to be proportional to the motor strain. The analysis soft-
ware Fit2D was used to convert the 2D data to 1D, by radially integrating over a 10˚ sector and
a 20-pixel-wide sector, respectively oriented parallel to the direction of loading. The sample-
to-detector distance and beam center were calibrated with standards. The fifth-order collagen
peak and the (0002) apatite peak were found by fitting the 1D datasets with a Gaussian and a
linear function. Changes in the position of the peak’s center divided by its location at zero,
constituted the strain in the collagen fibrils and mineral.
Murine bone cell culture
Bone cells were derived from cortical explants of mouse femur by adaptations of the outgrowth
method [39]. The diaphyseal region of femurs of six 8wk-old TIMP3-Tg/Tg mice and four WT
controls were stripped of all attendant periosteal soft tissue and were longitudinally bisected. The
bone marrow was flushed out with Dulbecco’s phosphate-buffered saline, without calcium and
magnesium (PBS−) (Invitrogen., Paisley, U.K.) and each half was cut into fragments (approxi-
mately 1mm). After three washes in PBS− the bone fragments were transferred into tissue cul-
ture flasks; the 6 WT bone chips were places into 6 separate flasks and the 4 Tg/Tg bone chips
were divided into 6 flasks (to ensure the resultant cultures were similar between eah genotype).
Dulbecco’s minimum essential medium (DMEM) containing 10% fetal bovine serum (FBS),
2 mM L-glutamine, and penicillin (100 IU/ml)/streptomycin (100 μg/ml) (Invitrogen.) was care-
fully added to each flask containing the bone chips and incubated at 37˚C in a humidified 5%
CO2 incubator. The cortical bone fragments were fed biweekly ensuring minimum disruption
of outgrowing cells. After 30days of incubation, cells were washed in PBS− and released with
0.05% trypsin and 0.02% EDTA in special salt solution (Invitrogen, Paisley, UK). Only first pas-
sage cells (P1) were used for subsequent analysis.
Cell counting
1000 cells/well were seeded onto a 48 well tissue culture plate and cultured for 18 days in
DMEM. Monolayers were rinsed with ice-cold PBS twice and fixed in 4% paraformaldehyde
for 15 minutes at room temperature. 500ul of PBS containing 50ul NucBlue™ Fixed Cell Stain
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(Invitrogen) was added to each well and incubated for 10 minutes at room temperature for dye
incorporation. PBS containing dye was removed and replaced with 500μl fresh PBS. Twelve
images of separate sections of each well were taken using Leica DMIRB inverted microscope
under 450-490nm fluorescent emission settings. DAPI positive nuclei were counted in each
image using Volocity™ software.
Alkaline phosphatase activity
25,000 cells/well were seeded onto 12 well plates and cells were maintained in the presence and
absence of osteogenic media (OM; containing 50ug/ml ascorbic acid and 2mM beta-glycero-
phosphate) with media changes every 3 days for 56 days. Cells were rinsed three times with
PBS, digested with 0.1% triton X-100, scraped off the plate and the cell suspension sonicated
(Ultrasonic disintegrator, MSE laboratories, Butte, MT). The protein assay was performed
with the bicinchoninic acid (BCA) protein assay reagent (Pierce, Rockford, IL). Alkaline phos-
phatase activity was measured in the lysates as described previously [40]. Enzyme activity assay
was performed in assay buffer (0.1 M diethanolamine, 1 mM MgCl2 and 2 mM p-nitrophenyl-
phosphate pH 10.5) added to cell homogenates. A standard curve was prepared with p-nitro-
phenol solutions. Incubation of standards and samples was performed at 37˚C for 10 min and
the reaction stopped by adding 0.3 M NaOH. Reaction mixtures were transferred into 96-well
plates and absorbance measured at 410 nm using a plate reader. Relative ALP activity is
defined as nanomoles of p-nitrophenol phosphate hydrolyzed per minute per milligram of
total protein. ALP activity was also determined by histochemical staining. Briefly, bone cells
were fixed in 4% paraformaldehyde, rinsed and treated with substrate naphthol AS-TR which
is subsequently hydrolysed in the presence of the enzyme. The introduction of fast blue dye
produces a coloured precipitate.
Total RNA extraction
Cells from the 6 bone chip flasks were pooled into 3 separate tubes (2 flasks pooled into 1) and
25,000 cells from these 3 tubes were seeded under basal or OM conditions in 12-well culture
plates for 56 days (each plate consisted of n = 3 WT wells cultured with normal media, n = 3
Tg/Tg wells cultured with normal media, n = 3 WT wells under OM conditions and n = 3 Tg/
Tg wells under OM conditions). This procedure was replicated three times independently to
yield nine total RNA preparations for each treatment and genotype. Total RNA was isolated
from cultured cells QIAZOL1 reagent (QIagen, UK) according to the manufacturer’s instruc-
tions. Briefly, RNA was extracted at 56 days of culture. Cells were washed three times in ice
cold PBS and lysed in QIAZOL reagent. The cell lysate was extracted with chloroform, and
total RNA was precipitated with isopropanol. The pellet was washed in 70% ethanol, and resus-
pended in a small volume of diethyl pyrocarbonate (DEPC)-treated distilled water. Extracted
RNA was treated with RNase-free DNase I (35 U/ml) for 30 min at 37˚C and then re-precipi-
tated using 3M sodium Acetate (Sigma Aldrich, UK). Total RNA concentration was measured
by NanoDrop spectroscopy at 260nm and 280nm. A260/A280 ratio of 1.7–2.0 was considered
to have sufficient purity. Samples were stored in a -80˚C freezer until analysis.
Gene expression
cDNA was prepared from the total RNA using the enzyme reverse transcriptase II. 100ng ran-
dom hexamers (Qiagen) were added to 200ng total RNA, incubated for 10 minutes at 70˚C
and transferred to ice. A reaction mixture of 5x First Strand buffer, 0.1M Dithiothreitol
(DTT), 10mM deoxynucleotide triphosphates (dNTPs) and 200 units Superscript II (all Invi-
trogen) was prepared in a total volume of 12μl and added to the RNA/random hexamer
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mixture. The reaction mixture was then run on a PCR cycler (Eppendorf) under the following
conditions: 25˚C for 10 minutes, 42˚C for 50 minutes and 70˚C for 15 minutes. The cDNA
was then diluted 6 fold in DNase/RNase free H2O and stored at -20˚C until use. Quantitative
Reverse transcriptase polymerase chain reaction (qRT-PCR) was performed on cDNA to
examine gene expression levels. PCR reactions were prepared in a total volume of 12μl, con-
taining SYBR Green Jumpstart Taq readymix (20mM Tris-Hcl pH 8.3, 100mM KCl, 7mM
MgCl2, 0.4mM dNTPs, Taq polymerase(Sigma Aldrich, UK) and DNAase, RNAase-free
dH2O, 0.5μM forward primer, 0.5μM reverse primer and 0.6μg cDNA. The mixture was cycled
on a PCR cycler (Biorad 384x) under the following conditions: 1 cycle of 94˚C for 5 minutes,
40 cycles of 94˚C for 10 seconds, 60˚C for 15 seconds and 72˚C for 30 seconds, followed by a
final cycle of 70˚C for 15 seconds. Results were analysed using the modified delta-delta CT
method [41]. Specific primer sequences (sequence from 5’ to 3’, forward and reverse respec-
tively) were: OCN (CATGAGGACCCTCTCTCTGC; TGGACATGAAGGCTTTGTCA),
COL1A1 (TGGCCCCATTGGTAACGTTGGT; AGGACCTTGTTTGCCGGGTTCA), Runx-
2 (TCTGCCGAGCTACGAAATGCCT; TGAAACTCTTGCCTCGTCCGCT), ALP
(CCTTGAAAAATGCCCTGAAA; CTTGGAGAGAGCCACAAAGG). Melting temperatures
for all of these sequences were 60˚C.
Statistical analyses
To compare WT with Tg/Tg samples Student’s t-tests were used. For in vitro data analysis,
One Way ANOVA test was used. Statistical significance was calculated using GraphPad Prism
software and p<0.05 was considered significant.
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